MedTech Acquisition Corporation Unit
MTACU
MTACU was delisted on the 10th of August, 2023.
4 hedge funds and large institutions have $8.06K invested in MedTech Acquisition Corporation Unit in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
33% less funds holding
Funds holding: 6 → 4 (-2)
98% less capital invested
Capital invested by funds: $444K → $8.06K (-$436K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$431K |
| 2 |
CS
Clear Street
New York
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $6.04K | +$2K | +200 | +49% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $2K | – | – | – |
|
|
DM
3
Deerfield Management
New York
| $10 | – | – | – |
|
4
Wells Fargo
San Francisco,
California
| $10 | – | – | – |
|
|
HF
5
HRT Financial
New York
| – | -$431K | -43,415 | Closed |
|
|
CS
6
Clear Street
New York
| – | -$7K | -724 | Closed |
|
MTACU Hedge Fund Activity: Q4 2022 in Review
4 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q4 2022, worth a combined $8.06K — down 98% from $444K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MTACU and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $2K. The largest seller was HRT Financial, exiting entirely with an estimated $431K sold.
- 4 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q4 2022, down from 6 in Q3 2022.
- Funds reported $8.06K of MedTech Acquisition Corporation Unit stock for Q4 2022, down 98% quarter-over-quarter.
- 0 funds opened new MedTech Acquisition Corporation Unit positions in Q4 2022 and 2 closed out, a net change of -2 holders.
- The largest MedTech Acquisition Corporation Unit buyer in Q4 2022 was UBS Group, an estimated $2K added.
- The largest MedTech Acquisition Corporation Unit seller in Q4 2022 was HRT Financial, an estimated $431K sold.
Based on aggregated 13F filings for Q4 2022.